A real-world pharmacovigilance study using disproportionality analysis of United States Food and Drug Administration Adverse Event Reporting System events for vinca alkaloids: comparing vinorelbine and Vincristine

This analysis highlights the need for ongoing research of the risks associated with vinorelbine and vincristine.